Dan Mercola

11.1k total citations
130 papers, 8.4k citations indexed

About

Dan Mercola is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dan Mercola has authored 130 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 32 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dan Mercola's work include Cancer-related Molecular Pathways (16 papers), Prostate Cancer Treatment and Research (15 papers) and Cancer Research and Treatments (11 papers). Dan Mercola is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), Prostate Cancer Treatment and Research (15 papers) and Cancer Research and Treatments (11 papers). Dan Mercola collaborates with scholars based in United States, Italy and United Kingdom. Dan Mercola's co-authors include Eileen D. Adamson, Véronique Baron, Frédéric Bost, Chaoting Liu, Ian de Belle, Antonella Calogero, Olga Potapova, E.J. Dodson, Guy Dodson and Zhenyu Jia and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Dan Mercola

130 papers receiving 8.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dan Mercola 6.0k 2.0k 1.4k 865 831 130 8.4k
John A. Hickman 6.9k 1.1× 3.3k 1.6× 1.4k 1.0× 930 1.1× 714 0.9× 184 10.8k
Frank A.E. Kruyt 5.7k 0.9× 2.3k 1.1× 1.7k 1.2× 888 1.0× 826 1.0× 140 7.9k
Janet E. Price 3.7k 0.6× 3.2k 1.6× 1.5k 1.1× 1.0k 1.2× 1.0k 1.2× 136 7.5k
Stephen W. Byers 5.2k 0.9× 1.9k 0.9× 1.3k 0.9× 578 0.7× 634 0.8× 138 8.3k
Edward V. Prochownik 6.4k 1.1× 2.1k 1.0× 1.8k 1.2× 902 1.0× 478 0.6× 170 8.6k
Jian Jian Li 5.4k 0.9× 2.3k 1.1× 2.1k 1.5× 1.1k 1.3× 1.0k 1.2× 196 9.5k
Aviv Gazit 5.3k 0.9× 3.3k 1.6× 913 0.6× 1.3k 1.5× 583 0.7× 99 9.7k
Philippe Dessen 6.4k 1.1× 2.3k 1.1× 1.9k 1.3× 1.7k 2.0× 666 0.8× 167 10.5k
Anthony D. Whetton 5.2k 0.9× 1.4k 0.7× 1.0k 0.7× 1.2k 1.4× 540 0.6× 277 8.9k
Jukka Westermarck 5.5k 0.9× 2.4k 1.2× 2.3k 1.6× 708 0.8× 599 0.7× 116 8.8k

Countries citing papers authored by Dan Mercola

Since Specialization
Citations

This map shows the geographic impact of Dan Mercola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Mercola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Mercola more than expected).

Fields of papers citing papers by Dan Mercola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Mercola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Mercola. The network helps show where Dan Mercola may publish in the future.

Co-authorship network of co-authors of Dan Mercola

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Mercola. A scholar is included among the top collaborators of Dan Mercola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Mercola. Dan Mercola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Vinay, Michael McClelland, James Nguyen, et al.. (2021). Expression of Endogenous Retroviral RNA in Prostate Tumors has Prognostic Value and Shows Differences among Americans of African Versus European/Middle Eastern Ancestry. Cancers. 13(24). 6347–6347. 7 indexed citations
2.
Draanen, Jenna van, Pamela L. Davidson, H Bour, et al.. (2016). Assessing Researcher Needs for a Virtual Biobank. Biopreservation and Biobanking. 15(3). 203–210. 17 indexed citations
3.
Lee, Chung, Zhenyu Jia, Farah Rahmatpanah, et al.. (2014). Role of the Adjacent Stroma Cells in Prostate Cancer Development and Progression: Synergy between TGF-βand IGF Signaling. BioMed Research International. 2014. 1–8. 16 indexed citations
4.
Rahmatpanah, Farah, Zhenyu Jia, Xin Chen, et al.. (2014). A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors. Oncotarget. 6(2). 1286–1301. 6 indexed citations
5.
Jia, Zhenyu, et al.. (2013). A Gradient Boosting Algorithm for Survival Analysis via Direct Optimization of Concordance Index. Computational and Mathematical Methods in Medicine. 2013. 1–8. 82 indexed citations
6.
Tian, Xuejiao, Sai‐Yang Zhang, Hong‐Min Liu, et al.. (2013). Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention. Current Cancer Drug Targets. 13(5). 558–579. 59 indexed citations
7.
Wang, Yipeng, Xiao-Qin Xia, Zhenyu Jia, et al.. (2010). In silico Estimates of Tissue Components in Surgical Samples Based on Expression Profiling Data. Cancer Research. 70(16). 6448–6455. 60 indexed citations
8.
Qi, Jianfei, Koh Nakayama, Robert D. Cardiff, et al.. (2010). Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors. Cancer Cell. 18(1). 23–38. 192 indexed citations
9.
Tang, Yaxiong, Anne R. Simoneau, Yi Guo, et al.. (2009). WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Molecular Cancer Therapeutics. 8(2). 458–468. 89 indexed citations
10.
Arora, Shilpi, Yipeng Wang, Zhenyu Jia, et al.. (2008). Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip. Genome biology. 9(11). R166–R166. 38 indexed citations
11.
Hewitt, Robert E., Peter H. Watson, Rajiv Dhir, et al.. (2008). Timing of consent for the research use of surgically removed tissue. Cancer. 115(1). 4–9. 20 indexed citations
12.
Krones‐Herzig, Anja, Shalu Mittal, Hongyan Liang, et al.. (2005). Early Growth Response 1 Acts as a Tumor Suppressor In vivo and In vitro via Regulation of p53. Cancer Research. 65(12). 5133–5143. 119 indexed citations
13.
Hayakawa, Jun, Shalu Mittal, Kemal Korkmaz, et al.. (2005). Identification of Promoters Bound by c-Jun/ATF2 during Rapid Large-Scale Gene Activation following Genotoxic Stress. Molecular Cell. 17(1). 161–161. 3 indexed citations
14.
Irone, M, et al.. (2002). Assessment of adequacy of ICU admission.. PubMed. 68(4). 201–7. 5 indexed citations
15.
Yagupsky, Pablo, Nir Peled, Nurith Porat, et al.. (2002). Increasing Incidence of Gonorrhea in Israel Associated with Countrywide Dissemination of a Ciprofloxacin-Resistant Strain. European Journal of Clinical Microbiology & Infectious Diseases. 21(5). 368–372. 15 indexed citations
16.
Parra, Eduardo, Tomas Mustelin, Mikael Dohlsten, & Dan Mercola. (2001). Identification of a CD28 Response Element in the CD40 Ligand Promoter. The Journal of Immunology. 166(4). 2437–2443. 26 indexed citations
17.
Virolle, Thierry, Eileen D. Adamson, Véronique Baron, et al.. (2001). The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nature Cell Biology. 3(12). 1124–1128. 349 indexed citations
18.
Shawler, Daniel L., Habib Fakhrai, Charles Van Beveren, et al.. (1997). Gene Therapy Approaches to Enhance Antitumor Immunity. Advances in pharmacology. 40. 309–337. 8 indexed citations
19.
Mercola, Dan. (1993). HIV infection and intravenous drug abuse: world perspective and epidemiology in Israel.. PubMed. 29(10 Suppl). 11–4. 2 indexed citations
20.
Mercola, Dan, et al.. (1988). Analysis of a transformed cell line using antisense c-fos RNA. Gene. 72(1-2). 253–265. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Hickman Breakdown of academic impact, for papers by Frank A.E. Kruyt Breakdown of academic impact, for papers by Janet E. Price Breakdown of academic impact, for papers by Stephen W. Byers Breakdown of academic impact, for papers by Edward V. Prochownik Breakdown of academic impact, for papers by Jian Jian Li Breakdown of academic impact, for papers by Aviv Gazit Breakdown of academic impact, for papers by Philippe Dessen Breakdown of academic impact, for papers by Anthony D. Whetton Breakdown of academic impact, for papers by Jukka Westermarck
Rankless by CCL
2026